The heparin management test: a new device for monitoring anticoagulation during coronary intervention

Paolo Bartolomeo, G Helft, Ag Zaman, Sg Worthley, S Chokron, C Le Pailleur, F Beygui, C Le Feuvre, Jp Metzger, A Vacheron, Mm Samama

Risultato della ricerca: Contributo in rivistaArticolo in rivista

5 Citazioni (Scopus)

Abstract

Whole blood coagulation analysers are widely used during percutaneous coronary interventions. The precise degree of anticoagulation in patients is important in this setting. The aim of this investigation was to compare the results obtained with ACT (Hemochron) and HMT, the Heparin Management Test (TAS) in patients undergoing percutaneous coronary interventions. Patients (n = 100) were enrolled prospectively. Each patient received 10,000 units of heparin. At the end of the procedure, the mean ACT was 284+/-31 seconds and the mean HMT was 292+/-33 seconds. The correlation between the two methods was highly significant (r = 0.64, p<0.001). The HMT correlates well with ACT values in patients undergoing percutaneous coronary interventions. Its use in the management of these patients should be considered.
Lingua originaleEnglish
pagine (da-a)481-485
Numero di pagine5
RivistaThrombosis Research
Volume96
Stato di pubblicazionePubblicato - 1999

Keywords

  • Angina, Unstable
  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Blood Coagulation
  • Blood Coagulation Tests
  • Drug Monitoring
  • Evaluation Studies as Topic
  • Female
  • Heparin
  • Humans
  • Injections, Intravenous
  • Linear Models
  • Male
  • Middle Aged
  • Prospective Studies
  • Reproducibility of Results
  • Whole Blood Coagulation Time

Fingerprint

Entra nei temi di ricerca di 'The heparin management test: a new device for monitoring anticoagulation during coronary intervention'. Insieme formano una fingerprint unica.

Cita questo